ICU Pupillometry Cohort Found Sedative Associations Without a Drug-Specific Diagnostic Signature

Pupil size can reflect medication as well as neurological pathology.

What the supplied source reports

The retrospective study analyzed 9,897 observations from 221 neurocritical-care patients. Dexmedetomidine was associated with smaller pupils and higher measured reactivity. Exploratory analyses associated several intravenous sedatives, including midazolam, with smaller pupil size after statistical adjustment.

Limits and uncertainty

The patients had acute intracranial disease and multiple exposures. Treatment was not randomized, and adjustment cannot remove all confounding. The findings do not establish a distinctive pupil pattern identifying midazolam or a threshold distinguishing sedation from new neurological injury.

Implications for forensic review

For a neurological or impairment opinion, align pupil observations with drug administration, lighting, baseline disease and serial examinations. A small pupil alone cannot identify the responsible substance. The study supports considering medication effects without dismissing an evolving abnormality as merely pharmacological.

Source and related reading

Source reviewed: Dexmedetomidine and Other Analgosedatives Alter Pupil Characteristics in Critically Ill Patients (PMC9243241). Forensic applications above are interpretive analysis of the supplied publication.